Concepedia

Publication | Open Access

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis

176

Citations

21

References

2020

Year

Abstract

ClinicalTrials.gov Identifier: NCT03315130.

References

YearCitations

Page 1